
    
      Subjects undergoing cardiac surgery are randomized into one of two groups.

        -  Group 1: Intravenous Lidocaine Group

        -  Group 2: Intravenous placebo Group

      Either Lidocaine or placebo is administered throughout surgery and 24 hours after surgery.

      Patients in both groups will undergo quality of life assessments and functional recovery
      assessments post-surgery.
    
  